MCPRX
Price
$27.54
Change
-$0.15 (-0.54%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

MCPRX vs RPTIX

Header iconMCPRX vs RPTIX Comparison
Open Charts MCPRX vs RPTIXBanner chart's image
MFS Mid Cap Growth R2
Price$27.54
Change-$0.15 (-0.54%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MCPRX vs RPTIX Comparison Chart
Loading...
VS
MCPRX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCPRX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. MCPRX (15B). RPTIX pays higher dividends than MCPRX: RPTIX (0.18) vs MCPRX (0.00). MCPRX was incepted earlier than RPTIX: MCPRX (21 years) vs RPTIX (9 years). MCPRX is a more actively managed with annual turnover of: 30.00 vs. RPTIX (21.70). MCPRX has a lower initial minimum investment than RPTIX: MCPRX (0) vs RPTIX (500000). MCPRX annual gain was more profitable for investors over the last year : 26.50 vs. RPTIX (14.81). MCPRX return over 5 years is better than : 46.12 vs. RPTIX (15.09).
MCPRXRPTIXMCPRX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years9 years-
Gain YTD11.9699.127131%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets15B31.4B48%
Annual Yield % from dividends0.000.18-
Returns for 1 year26.5014.81179%
Returns for 3 years-5.01-13.5737%
Returns for 5 years46.1215.09306%
Returns for 10 years104.20N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp